Last reviewed · How we verify
SOC INSTI-based ART
At a glance
| Generic name | SOC INSTI-based ART |
|---|---|
| Sponsor | ViiV Healthcare |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV (PHASE1)
- Study of GS-3242 in Participants With HIV-1; Substudy-05 (PHASE1)
- INSTI's For The Management of HIV-associated TB (PHASE2)
- Zn Supplementation in HIV Immunological Non Responders (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SOC INSTI-based ART CI brief — competitive landscape report
- SOC INSTI-based ART updates RSS · CI watch RSS
- ViiV Healthcare portfolio CI